DNA And Gene Chip: A Leading Driver Behind Early Cancer Detection Driving Growth Of DNA And Gene Chip Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the DNA And Gene Chip Industry Market Size Be by 2025?
The scale of the dna and gene chip market has gone through a swift expansion in recent times. The market's growth is predicted to rise from an estimate of $8.19 billion in 2024 to approximately $9.2 billion in 2025, marking a compound annual growth rate (CAGR) of 12.2%. The past growth can be linked to the progress in genomic research, the emergence of personalized medicine, breakthroughs in the human genome project, advances in drug discovery and development, and identification of disease biomarkers.

What's the Long-Term Growth Forecast for the DNA And Gene Chip Market Size Through 2029?
Rapid expansion is predicted for the dna and gene chip market in the coming years, with the market size anticipated to reach $15.13 billion by 2029, expanding at a compound annual growth rate (CAGR) of 13.3%. The projected growth in this timeframe can be ascribed to developments in precision medicine, an increase in biomarker discovery, the rise of personalized therapeutics, applications in cancer research and amplified research funding. Key trends identified for the forecast period encompass technological advancements, product innovation, adherence to regulatory frameworks, attention on rare diseases, and sustained cost reductions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

What Are the Key Growth Drivers Fueling the DNA And Gene Chip Market Expansion?
The increasing need for early diagnosis of cancer is a significant factor in boosting the DNA and gene chip market's expansion. Cancer encompasses a wide range of conditions that can form in virtually any organ or tissue throughout the body. This occurs when irregular cells multiply beyond control, break traditional cell boundaries to invade nearby organs, and disseminate to other parts of the body. DNA and gene chips are utilized to assess gene expression profiles, identify the genetic and epigenetic terrain, and measure the genomic regulatory elements captured by cancer transcription elements in cancerous cells. As per the American Cancer Society, a community-based, voluntary health organization in the US, around 1.9 million new cancer instances and 609,360 cancer-related fatalities are expected to occur in 2022. Consequently, the increasing need for early diagnosis of cancer is stimulating the growth of the DNA and gene chip market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

What Are the Key Trends Driving DNA And Gene Chip Market Growth?
Trend one highlights the growing trend of strategic partnerships and collaborations in the DNA and gene chip market. Several companies in this field are striving to solidify their industry position through partnerships. An example of this is the four-year strategic partnership established in June 2022 between Avesthagen Limited, a system biology company based in India, and Wipro Limited, an Indian technology company. This partnership permitted them to carry out a project named Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer-related genomics sequencing services. Moreover, in May 2022, US-based company Thermo Fisher Scientific partnered with Qatar Genome Program, a member of Qatar Foundation, to create an Axiom custom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries. This array, featuring 800,000 variants, aims to push forward genomic research into conditions including diabetes, cardiovascular diseases, autism, and cancer. The collaboration aligns with Qatar's national vision for better population health and the progression of precision medicine among the Arab population worldwide, with Thermo Fisher's Axiom microarray technology propelling these precision medicine initiatives.

How Is the DNA And Gene Chip Market Segmented?
The dna and gene chip market covered in this report is segmented -

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp

Which Companies Are Leading the Charge in DNA And Gene Chip Market Innovation?
Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

Which Regions Are Leading the Global DNA And Gene Chip Market in Revenue?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8205

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.